NO20012190L - Heparanase aktivitetsnöytraliserende anti-heparanase monoklonalt antistoff - Google Patents
Heparanase aktivitetsnöytraliserende anti-heparanase monoklonalt antistoffInfo
- Publication number
- NO20012190L NO20012190L NO20012190A NO20012190A NO20012190L NO 20012190 L NO20012190 L NO 20012190L NO 20012190 A NO20012190 A NO 20012190A NO 20012190 A NO20012190 A NO 20012190A NO 20012190 L NO20012190 L NO 20012190L
- Authority
- NO
- Norway
- Prior art keywords
- heparanase
- monoclonal antibody
- neutralizing anti
- activity neutralizing
- antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01166—Heparanase (3.2.1.166)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
- G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/186,200 US6562950B2 (en) | 1997-09-02 | 1998-11-04 | Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| PCT/US1999/025451 WO2000025817A1 (en) | 1998-11-04 | 1999-10-28 | Heparanase activity neutralizing anti-heparanase monoclonal antibody |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20012190D0 NO20012190D0 (no) | 2001-05-03 |
| NO20012190L true NO20012190L (no) | 2001-06-12 |
Family
ID=22684036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012190A NO20012190L (no) | 1998-11-04 | 2001-05-03 | Heparanase aktivitetsnöytraliserende anti-heparanase monoklonalt antistoff |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6562950B2 (de) |
| EP (1) | EP1126878B1 (de) |
| JP (1) | JP2002543759A (de) |
| AT (1) | ATE442859T1 (de) |
| AU (1) | AU751170B2 (de) |
| CA (1) | CA2349622A1 (de) |
| DE (1) | DE69941435D1 (de) |
| ES (1) | ES2332960T3 (de) |
| IL (1) | IL142866A0 (de) |
| NO (1) | NO20012190L (de) |
| WO (1) | WO2000025817A1 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020088019A1 (en) * | 1997-09-02 | 2002-07-04 | Oron Yacoby-Zeevi | Methods of and pharmaceutical compositions for improving implantation of embryos |
| US20030161823A1 (en) * | 1998-08-31 | 2003-08-28 | Neta Ilan | Therapeutic and cosmetic uses of heparanases |
| US20040213789A1 (en) * | 1997-09-02 | 2004-10-28 | Oron Yacoby-Zeevi | Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies |
| US6177545B1 (en) * | 1997-09-02 | 2001-01-23 | Insight Strategy & Marketing Ltd. | Heparanase specific molecular probes and their use in research and medical applications |
| US6699672B1 (en) * | 1997-09-02 | 2004-03-02 | Insight Biopharmaceuticals Ltd. | Heparanase specific molecular probes and their use research and medical applications |
| US20030217375A1 (en) * | 1998-08-31 | 2003-11-20 | Eyal Zcharia | Transgenic animals expressing heparanase and uses thereof |
| AU2878600A (en) * | 1999-03-01 | 2000-09-21 | Hadasit Medical Research Services & Development Company Ltd | Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells |
| US6784288B2 (en) * | 2001-11-08 | 2004-08-31 | Ortho-Mcneil Pharmaceutical, Inc. | Polynucleotide and polypeptide sequences of monkey cathepsin S |
| WO2004043989A2 (en) * | 2002-11-07 | 2004-05-27 | Medarex, Inc. | Human monoclonal antibodies to heparanase |
| US20060269552A1 (en) * | 2003-06-09 | 2006-11-30 | Oron Yacoby-Zeevi | Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies |
| IL160025A0 (en) * | 2004-01-22 | 2004-06-20 | Hadasit Med Res Service | Heparanase inhibitors directed against a specific sequence essential for heparanase catalytic activity and uses thereof |
| US7391863B2 (en) * | 2004-06-23 | 2008-06-24 | Vocollect, Inc. | Method and system for an interchangeable headset module resistant to moisture infiltration |
| USD549694S1 (en) | 2005-11-15 | 2007-08-28 | Vocollect, Inc. | Headset |
| USD552595S1 (en) | 2005-11-16 | 2007-10-09 | Vocollect, Inc. | Control panel for a headset |
| US8417185B2 (en) | 2005-12-16 | 2013-04-09 | Vocollect, Inc. | Wireless headset and method for robust voice data communication |
| US7773767B2 (en) | 2006-02-06 | 2010-08-10 | Vocollect, Inc. | Headset terminal with rear stability strap |
| US7885419B2 (en) | 2006-02-06 | 2011-02-08 | Vocollect, Inc. | Headset terminal with speech functionality |
| IL184671A0 (en) * | 2007-07-17 | 2008-12-29 | Hadasit Med Res Service | Substances directed to heparanase c-terminal domain-or substance derived therefrom and uses thereof as modulators of heparanas biological activities |
| USD605629S1 (en) | 2008-09-29 | 2009-12-08 | Vocollect, Inc. | Headset |
| WO2010041060A1 (en) * | 2008-10-08 | 2010-04-15 | Medimmune Limited | Targeted binding agents directed to heparanase and uses thereof 463 |
| US8160287B2 (en) | 2009-05-22 | 2012-04-17 | Vocollect, Inc. | Headset with adjustable headband |
| US8438659B2 (en) | 2009-11-05 | 2013-05-07 | Vocollect, Inc. | Portable computing device and headset interface |
| EP2507265B1 (de) * | 2009-12-01 | 2016-05-11 | Compugen Ltd. | Heparanase Spice-Variante T5 spezifischer Antikörper und dessen Verwendung. |
| EP3362093A4 (de) | 2015-10-13 | 2019-05-08 | Technion Research & Development Foundation Limited | Heparanase-neutralisierende monoklonale antikörper |
| US11787783B2 (en) | 2016-12-13 | 2023-10-17 | Beta Therapeutics Pty Ltd | Heparanase inhibitors and use thereof |
| WO2018107200A1 (en) | 2016-12-13 | 2018-06-21 | Beta Therapeutics Pty Ltd | Heparanase inhibitors and use thereof |
| CN116648506A (zh) * | 2020-07-06 | 2023-08-25 | 技术研发基金会有限公司 | 乙酰肝素酶中和a54单克隆抗体 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5262403A (en) * | 1986-03-10 | 1993-11-16 | Board Of Regents, The University Of Texas System | Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness of metastatic profusion-II |
| US4859581A (en) * | 1986-03-10 | 1989-08-22 | Board Of Regents, The University Of Texas System | Endoglycosidase assay |
| US5362641A (en) * | 1989-08-23 | 1994-11-08 | Hadassah Medical Organization Kiryat Hadassah | Heparanase derived from human Sk-Hep-1 cell line |
| US5736137A (en) * | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| US6177545B1 (en) * | 1997-09-02 | 2001-01-23 | Insight Strategy & Marketing Ltd. | Heparanase specific molecular probes and their use in research and medical applications |
| US20040213789A1 (en) * | 1997-09-02 | 2004-10-28 | Oron Yacoby-Zeevi | Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies |
| JP2002510462A (ja) * | 1997-10-28 | 2002-04-09 | ジ・オーストラリアン・ナショナル・ユニバーシティー | 哺乳類のエンドグルクロニダーゼをコードする単離された核酸分子およびその使用 |
| GB9802725D0 (en) * | 1998-02-09 | 1998-04-08 | Ciba Geigy Ag | Organic compounds |
-
1998
- 1998-11-04 US US09/186,200 patent/US6562950B2/en not_active Expired - Fee Related
-
1999
- 1999-10-28 IL IL14286699A patent/IL142866A0/xx unknown
- 1999-10-28 CA CA002349622A patent/CA2349622A1/en not_active Abandoned
- 1999-10-28 JP JP2000579256A patent/JP2002543759A/ja active Pending
- 1999-10-28 ES ES99956781T patent/ES2332960T3/es not_active Expired - Lifetime
- 1999-10-28 AT AT99956781T patent/ATE442859T1/de not_active IP Right Cessation
- 1999-10-28 AU AU13314/00A patent/AU751170B2/en not_active Ceased
- 1999-10-28 DE DE69941435T patent/DE69941435D1/de not_active Expired - Lifetime
- 1999-10-28 WO PCT/US1999/025451 patent/WO2000025817A1/en not_active Ceased
- 1999-10-28 EP EP99956781A patent/EP1126878B1/de not_active Expired - Lifetime
-
2001
- 2001-05-03 NO NO20012190A patent/NO20012190L/no not_active Application Discontinuation
-
2003
- 2003-02-19 US US10/368,044 patent/US6946131B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2349622A1 (en) | 2000-05-11 |
| US20020068061A1 (en) | 2002-06-06 |
| ATE442859T1 (de) | 2009-10-15 |
| EP1126878A1 (de) | 2001-08-29 |
| EP1126878A4 (de) | 2003-04-16 |
| AU751170B2 (en) | 2002-08-08 |
| US6946131B2 (en) | 2005-09-20 |
| JP2002543759A (ja) | 2002-12-24 |
| US20030181687A1 (en) | 2003-09-25 |
| AU1331400A (en) | 2000-05-22 |
| US6562950B2 (en) | 2003-05-13 |
| ES2332960T3 (es) | 2010-02-15 |
| IL142866A0 (en) | 2002-03-10 |
| EP1126878B1 (de) | 2009-09-16 |
| DE69941435D1 (de) | 2009-10-29 |
| WO2000025817A1 (en) | 2000-05-11 |
| NO20012190D0 (no) | 2001-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20012190D0 (no) | Heparanase aktivitetsnöytraliserende anti-heparanase monoklonalt antistoff | |
| NO20013561L (no) | Oljer med heterogene kjedelengder | |
| PL353750A1 (en) | Dosages for treatment with anti-erbb2 antibodies | |
| EP1069185A4 (de) | Humanisierter antikörper gegen den menschlichen gewebefaktor (tf) und verfahren für die konstruktion eines solchen humanisierten antikörpers. | |
| GB2368796A (en) | Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies | |
| EA199900758A1 (ru) | Малые молекулы, полезные при лечении воспалительных заболеваний | |
| ES2164182T3 (es) | Benzociclopentanoxazolidinonas que contienen heteroatomos con actividad antibacteriana. | |
| TR200000755T2 (tr) | Karşıt olma-karşı gelme bozukluğunun tedavisi. | |
| ES2159318T3 (es) | Inhibidores de la proteina quinasa c. | |
| FI941572L (fi) | Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä | |
| PT1304327E (pt) | Tiazolididas e pirrolididas de glutamina bem como a sua utilizacao como inibidores de dipeptidilpeptidase iv | |
| MY140767A (en) | Compounds, methods and compositions | |
| NO975690D0 (no) | Fremgangsmåte for forbedring av dyrehelse | |
| WO2001043806A3 (de) | Atemzugsvolumenabhängige gasdosierung | |
| EP0590747A3 (de) | Beta-6-N-Acetylglukosaminyltransferase, das Akzeptor-Molekül, Leukosialin und Verfahren zur Klonierung enzymatisch-aktiven Proteinen. | |
| IS6105A (is) | Aðferð til meðferðar á netjuhersli með notkun mótlyfs við integríninu alfa-4 | |
| ES2164434T3 (es) | Tratamiento topico de psoriasis que utiliza anticuerpos neutralizantes de il-8. | |
| AR015837A1 (es) | Metodo de transformacion de plantas. | |
| FI952660L (fi) | Ferriittinen ruostumaton teräs, jolla on parannettu koneistettavuus | |
| ES2080037T1 (es) | Medicamento de uso topico con actividad cicatrizante. | |
| MXPA02006167A (es) | Promocion de la angiogenesis con survivina. | |
| WO1998046632A3 (de) | Inhibitoren für den urokinaserezeptor | |
| WO2004108065A3 (en) | Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies | |
| DE60318065D1 (de) | Fcyriia-transgenes tiermodell für autoimmunkrankheit | |
| NO913281L (no) | Vandig loesning, saerlig til rensing av hoeyfasthetsstaal. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |